Editorial · 30 May 2025
Conference abstractPublished 5 Dec 2015
A new, safe and reproducible procedure to improve soft tissue augmentation outcomes
Bioscience Clinic Middle East, UAE
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: In the field of fat graft, the combination of autologous in vitro-expanded ADSC with fat for clinical applications overcomes some of the problems of fat graft alone, as variable resorption and survival rates, but there is still a high technical variability that could negatively affect the clinical outcomes. A standardized and reproducible technique to in vitro expanded ADSC, that can increase the viability of the transplanted cells, is required. Method: In this frame, we decided to explore injection of in vitro expanded autologous ADSC in association to autologous fat for breast augmentation and face rejuvenation. ADSC were isolated from autologous fat and expanded according to GMP procedures, using a cell growth medium supplemented with pooled human platelet lysate, which provided a significantly higher proliferation rate compared to FBS. Before release, cells were tested for sterility and biological safety. In vitro and in vivo experiments were performed according to the European Pharmacopoeia and no signs of tumorigenesis were detected, suggesting the biological safety of expanded ADSC. Cells were administered subcutaneously in association with fat to 6 patients for breast augmentation and 5 patients for facial rejuvenation. Evaluation of the treated areas was performed prior and after treatment and 4 months after by means of MRI and bilateral mammography, in compliance with an established follow-up protocol. Results: Follow-up reports highlight an increase in the volume of adipose tissue in treated areas, due to ADSC-mediated enhancement of fat graft viability and suggest that the ratio ADSC/fat is critical for graft retention. No adverse events have been recorded. Conclusion: Our study confirms that fat graft enriched with in vitro expanded autologous ADSC is a safe and efficient approach for soft tissues augmentation, since it reduces fat graft resorption rate and ensures durable results. Moreover, thanks to our highly reproducible protocol, in vitro expansion of ADSC increases the number of cells to the quantities required to achieve therapeutic results and overcomes the limited amount of stem cells that can be harvested from a single patient in a single surgery.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Biotechnology & Biomaterials.
Editorial · 30 May 2025
3D Bioprinting of Vascularized Tissue Constructs Using Bioink-Embedded Endothelial Cells
Editorial · 30 May 2025
Development of Flexible Bioelectronic Interfaces for Real-Time Neural Signal Monitoring
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Biotechnology & Biomaterials
- SubjectBiochemistry & Biotechnology
- SubjectMaterials Science
- BylineArticles whose byline prints “Giuseppe Mucci”